Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Takeichi Yoshida

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0717-943X; OpenAlex author ID A5101530184. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
50
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 3 papers · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 11

  1. First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. Co-author DOI 10.1158/2159-8290.cd-25-2245↗
  2. Personalizing CA125 Levels Using Tumor Marker Variants: A Case-Control Analysis of Diagnostic Performance for Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-25-1050↗
  3. Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer. Co-author DOI 10.1200/jco.23.01573↗
  4. Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. Co-author DOI 10.1245/s10434-024-14942-5↗
  5. Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2020.11.006↗
  6. Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2021.10.008↗
  7. Endoplasmic stress-inducing variants in carboxyl ester lipase and pancreatic cancer risk. First author DOI 10.1016/j.pan.2022.08.004↗
  8. Utility of Contrast-Enhanced Harmonic Endoscopic Ultrasonography for Early Diagnosis of Small Pancreatic Cancer. Co-author DOI 10.3390/diagnostics10010023↗
  9. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. First author DOI 10.1007/s00535-018-1519-2↗
  10. Endoscopic Ultrasound for Early Diagnosis of Pancreatic Cancer. Co-author DOI 10.3390/diagnostics9030081↗
  11. Tumor vessel depiction with contrast-enhanced endoscopic ultrasonography predicts efficacy of chemotherapy in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e31827fe94c↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Goggins · 7 shared papers, 2022–2026 · strength 1.26
  2. Jin Peng He · 5 shared papers, 2022–2025 · strength 0.91
  3. Marcia Irene Canto · 5 shared papers, 2022–2025 · strength 0.86
  4. Amanda L. Blackford · 4 shared papers, 2022–2025 · strength 0.75
  5. Richard Andrew Burkhart · 4 shared papers, 2022–2024 · strength 0.66
  6. Elizabeth Abou Diwan · 3 shared papers, 2024–2026 · strength 0.58
  7. Anne Marie Lennon · 3 shared papers, 2022–2024 · strength 0.46
  8. Yasunobu Yamashita · 4 shared papers, 2013–2020 · strength 0.40
  9. Yohei Ando · 2 shared papers, 2024 · strength 0.37
  10. Helena Saba · 2 shared papers, 2024 · strength 0.37
  11. James R. Eshleman · 2 shared papers, 2024 · strength 0.37
  12. Masayuki Kitano · 3 shared papers, 2019–2020 · strength 0.36
  13. Koji Tamura · 2 shared papers, 2022 · strength 0.29
  14. Toshiya Abe · 2 shared papers, 2022 · strength 0.28
  15. Masataka Hayashi · 1 shared paper, 2025 · strength 0.25
  16. Yuto Hozaka · 1 shared paper, 2025 · strength 0.25
  17. Katsuya Hirose · 1 shared paper, 2025 · strength 0.25
  18. Elham Afghani · 1 shared paper, 2025 · strength 0.25
  19. Masahiro Itonaga · 3 shared papers, 2013–2020 · strength 0.24
  20. Dimitrios N. Sidiropoulos · 1 shared paper, 2026 · strength 0.21
  21. Hao Wang · 1 shared paper, 2026 · strength 0.21
  22. Saurav Daniel Haldar · 1 shared paper, 2026 · strength 0.21
  23. Marina Baretti · 1 shared paper, 2026 · strength 0.21
  24. Luciane Tsukamoto Kagohara · 1 shared paper, 2026 · strength 0.21
  25. Mark M. Yarchoan · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.